<DOC>
	<DOCNO>NCT01398670</DOCNO>
	<brief_summary>This randomize , parallel group comparison immunogenicity safety Wockhardt 's Insulin analogue Lispro lispro Mix Eli Lilly 's Insulin analogue Humalog® Humalog® Mix patient Type 1 Diabetes Mellitus</brief_summary>
	<brief_title>Immunogenicity Study Wockhardt 's Insulin Lispro/Lispro Mix Basal Bolus Regimen Type 1 Diabetics</brief_title>
	<detailed_description>To evaluate compare Immunogenicity safety Wockhardt 's Insulin analogue Lispro lispro Mix Eli Lilly 's Insulin analogue Humalog® Humalog® Mix Type I Diabetic patient .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<criteria>1 . Patients understand nature study willing provide write informed consent . 2 . Patients prediagnosed case type1 diabetes period less 1 year 3 . Male Female Patients ≥ 18 &lt; 55 year age . 4 . Patients body mass index ( BMI ) 18.0 30.0 kg/m2 5 . Patients cooperative , reliable , agree regular injection insulin willing comply protocol procedure . 6 . Ability use self glucosemonitoring device self inject insulin . 1 . Females pregnant lactating , practice adequate contraception . 2 . A Patient compromise hepatic renal function 3 . A Patient employee Investigator , patient direct involvement trial trial direction Investigator . 4 . A Patient treat investigational agent device within previous 30 day , plan use investigational drug device , previously randomize trial . 5 . A Patient history evidence allergy insulin preparation . 6 . A Patients currently receive receive , within last year , immunomodulator medication . 7 . Patients unlikely comply study protocol e.g . unable return periodically subsequent visit . 8 . Patients judge investigator inappropriate participate study reason mention .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Type I Diabetes</keyword>
	<keyword>Wockhardt 's Insulin analogue Lispro</keyword>
	<keyword>Humalog®</keyword>
	<keyword>Humalog Mix</keyword>
	<keyword>Wockhardt</keyword>
	<keyword>Biosimilar</keyword>
	<keyword>Phase 3</keyword>
</DOC>